Publishing research using ab31891? Please let us know so that we can cite the reference in this datasheet.
ab31891 has been referenced in 3 publications.
Globerson-Levin A et al.Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.Mol Ther 22:1029-38 (2014).
Hurrell T & Outhoff K Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?Onco Targets Ther 6:693-701 (2013).
Zhao Y et al.A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.J Immunol 183:5563-74 (2009).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"